Won‐Mook Choi, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Young‐Suk Lim, Han Chu Lee, Young‐Hwa Chung, Young‐Sang Lee, Sook Ryun Park, Min‐Hee Ryu, Baek‐Yeol Ryoo, So Jung Lee, Kang Mo Kim – 16 June 2020 – Regorafenib and nivolumab are drugs approved for second‐line treatment of patients with hepatocellular carcinoma (HCC) after sorafenib failure. However, the effectiveness of regorafenib and nivolumab following sorafenib has not been directly compared.

Zobair M. Younossi, Mary E. Rinella, Arun J. Sanyal, Stephen A. Harrison, Elizabeth M. Brunt, Zachary Goodman, David E. Cohen, Rohit Loomba – 16 June 2020 – Despite the substantial gains in our understanding of NAFLD/NASH over the past 2 decades, there has been some dissatisfaction with the terminology “non‐alcoholic” which overemphasizes “alcohol” and underemphasizes the root cause of this liver disease, namely, the predisposing metabolic risk factors. As a potential remedy, a name change from NAFLD to metabolic associated fatty liver disease (MAFLD) has been proposed.

Zhiheng Zhang, Yunhua Tang, Qiang Zhao, Linhe Wang, Caihui Zhu, Weiqiang Ju, Dongping Wang, Lu Yang, Linwei Wu, Maogen Chen, Shanzhou Huang, Ningxin Gao, Zebin Zhu, Yixi Zhang, Chengjun Sun, Wei Xiong, Yuekun Shen, Yi Ma, Anbin Hu, Xiaofeng Zhu, Jian Rong, Changjie Cai, Zhiyong Guo, Xiaoshun He – 15 June 2020 – It has been shown that normothermic machine perfusion (NMP), a novel preservation method, is able to assess and resuscitate liver grafts with risk factors. However, there is no consistent criteria for the assessment of liver grafts with NMP.

Paolo De Simone, Fabio Melandro, Emanuele Balzano, Giovanni Tincani, Gabriele Catalano, Davide Ghinolfi, Juri Ducci, Paola Carrai, Stefania Petruccelli, Giandomenico Biancofiore – 15 June 2020

Dieter C. Broering, Yasser Elsheikh, Yasir Alnemary, Ahmed Zidan, Ahmed Elsarawy, Yahia Saleh, Saleh Alabbad, Mark Sturdevant, Yao‐Ming Wu, Roberto I. Troisi – 15 June 2020 – Robotic right lobe donor hepatectomy (RRLDH) is rarely performed, and data concerning its safety and efficacy are lacking. Here we compare our series of RRLDHs with a similar cohort undergoing open right lobe donor hepatectomy (ORLDH) with a propensity score–matched (PSM) analysis.

Jinhang Zhang, Yanping Li, Qinhui Liu, Ya Huang, Rui Li, Tong Wu, Zijing Zhang, Jian Zhou, Hui Huang, Qin Tang, Cuiyuan Huang, Yingnan Zhao, Guorong Zhang, Wei Jiang, Li Mo, Jian Zhang, Wen Xie, Jinhan He – 14 June 2020

Louise J.M. Alferink, Djawad Radjabzadeh, Nicole S. Erler, Dina Vojinovic, Carolina Medina‐Gomez, André G. Uitterlinden, Robert J. Knegt, Najaf Amin, M. Arfan Ikram, Harry L.A. Janssen, Jessica C. Kiefte‐de Jong, Herold J. Metselaar, Cornelia M. Duijn, Robert Kraaij, Sarwa Darwish Murad – 12 June 2020

Corinne Antoine, Carine Jasseron, Federica Dondero, Eric Savier, the French National Steering Committee of Donors After Circulatory Death – 12 June 2020 – A national program of controlled donation after circulatory death (cDCD) began in France in 2014 involving the use of a standardized national protocol that involves the systematic use of normothermic regional perfusion (NRP). In this article, we describe in detail the French cDCD program. Between January 1, 2015, and December 31, 2018, 225 livers were offered for donation, resulting in 123 cDCD liver transplantations (LTs).

Jordyn Silverstein, Garrett Roll, Jennifer L. Dodge, Joshua D. Grab, Francis Y. Yao, Neil Mehta – 12 June 2020 – Liver transplantation (LT) recipients with hepatocellular carcinoma (HCC) receive a higher proportion of livers from donation after circulatory death (DCD) donors compared with non‐HCC etiologies. Nevertheless, data on outcomes in patients with HCC receiving DCD grafts are limited. We evaluated the influence of DCD livers on post‐LT outcome among HCC patients.

Chen Xie, Jian‐Hong Fang, Shi‐Mei Zhuang, the other authors – 11 June 2020